Reza Zadno's guest appearances

Reza Zadno

OIS Podcast

Nick Curtis

Jay Cormier

Brent Saunders

Daniel Chao

David Muller

Andrew Chang

David Tanzer

Ken Mills

Bill Link

Patrick Mooney

Diana Driscoll

Brent Jones

Ponders IPO

Jay Duker

Steve Charles

OwlTail

Avedro Inc. went public on Feb. 14, raising $70 million with its shares pricing at, coincidentally, $14. We talk with Reza Zadno, CEO and president, about the IPO process, which, as you might imagine, she says is as difficult as it looks. We’ll also talk business. Avedro, of course, is a commercial enterprise now, reporting growing sales on its Corneal Crosslinking System that can be used to treat keratoconus, a non-inflammatory eye condition that weakens and misshapes the cornea. What does the future hold for the start-up?

<p>Avedro Inc. went public on Feb. 14, raising $70 million with its shares pricing at, coincidentally, $14. We talk with Reza Zadno, CEO and president, about the IPO process, which, as you might imagine, she says is as difficult as it looks. We’ll also talk business. Avedro, of course, is a commercial enterprise now, reporting growing sales on its Corneal Crosslinking System that can be used to treat keratoconus, a non-inflammatory eye condition that weakens and misshapes the cornea. What does the future hold for the start-up?</p>

Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential

Bill Meury

The OIS Podcast returns with a double feature. Avedro CEO Reza Zadno talks about the company's latest $25 million round. Also, Bill Meury, CCO of Allergan, visits at OIS@ASCRS to talk about the company's appetite for acquiring innovation. You can watch our April 12 interview with Dr. Zadno at OIS@ASCRS here. You can also watch the podcast interview with Bill Meury, which was conducted at OIS@ASCRS.

OIS Podcast Talks Fund-raising with Avedro's Reza Zadno, Innovation with Allergan's Bill Meury